Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Analysts are anticipating strong growth driven by the robust sales of Lilly's blockbuster medications, particularly recent launches. However, there are also concerns about potential challenges from re